 | Why Adaptimmune Therapeutics, Atreca, and CRISPR Therapeutics All Tanked In March
www.msn.com - April 6 at 4:24 PM |
 | Is CRISPR Therapeutics Stock a Buy?
www.fool.com - April 5 at 3:55 PM |
 | Piper Sandler Reiterates "Buy" Rating for Crispr Therapeutics (NASDAQ:CRSP)
www.americanbankingnews.com - April 2 at 4:42 PM |
| Crispr Therapeutics AG (NASDAQ:CRSP) Sees Large Growth in Short Interest
www.americanbankingnews.com - April 1 at 7:20 AM |
 | First Week of May 8th Options Trading For CRISPR Therapeutics (CRSP)
www.nasdaq.com - March 30 at 4:24 PM |
 | Hedge Funds Have Never Been This Bullish On CRISPR Therapeutics AG (CRSP)
finance.yahoo.com - March 27 at 2:22 PM |
| Brokerages Anticipate Crispr Therapeutics AG (NASDAQ:CRSP) Will Announce Quarterly Sales of $6.35 Million
www.americanbankingnews.com - March 27 at 4:43 AM |
| Analysts Expect Crispr Therapeutics AG (NASDAQ:CRSP) Will Announce Earnings of -$1.09 Per Share
www.americanbankingnews.com - March 25 at 6:26 AM |
| Crispr Therapeutics AG (NASDAQ:CRSP) Sees Significant Growth in Short Interest
www.americanbankingnews.com - March 15 at 6:34 AM |
| Crispr Therapeutics AG (NASDAQ:CRSP) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 14 at 2:18 AM |
| CRISPR Therapeutics Enters Oversold Territory (CRSP)
www.nasdaq.com - March 12 at 2:46 PM |
| CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know
finance.yahoo.com - March 10 at 7:40 PM |
| Researchers Create New CRISPR Gene-Editing System for Plants
www.fool.com - March 9 at 10:20 PM |
| CRSP Mar 2020 53.500 call
finance.yahoo.com - March 7 at 8:40 AM |
| CRSP April 24th Options Begin Trading
www.nasdaq.com - March 5 at 3:30 PM |
| Horrible Week Finally Comes to an End
finance.yahoo.com - March 2 at 11:42 AM |
| Can CRISPR Therapeutics Double Your Money in 2020?
www.fool.com - February 28 at 8:50 AM |
 | CRISPR Should Continue The Bullish Pace From 2019
seekingalpha.com - February 23 at 2:05 PM |
| Stock To Watch: CRISPR Therapeutics (CRSP)
www.nasdaq.com - February 13 at 1:29 PM |
| CRISPR Therapeutics EPS beats by $1.19, beats on revenue
seekingalpha.com - February 12 at 9:29 PM |
| CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - February 12 at 9:29 PM |
| CRISPR Therapeutics AG (CRSP) Beats Q4 Earnings and Revenue Estimates
finance.yahoo.com - February 12 at 9:29 PM |
| CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - February 12 at 4:28 PM |
| CRISPR Therapeutics Shows Market Leadership With Jump To 92 RS Rating
finance.yahoo.com - February 11 at 5:32 PM |
| First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results
www.fool.com - February 7 at 6:15 PM |
| CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
finance.yahoo.com - February 6 at 7:09 PM |
| Here's Why CRISPR Stocks Fell in January
www.fool.com - February 5 at 1:31 PM |
| CRISPR Therapeutics AG (CRSP) Stock Moves -0.9%: What You Should Know
finance.yahoo.com - January 31 at 10:44 PM |
| Vertex (VRTX) Q4 Earnings Beat on Solid CF Product Sales
finance.yahoo.com - January 31 at 5:44 PM |
| March 13th Options Now Available For CRISPR Therapeutics (CRSP)
www.nasdaq.com - January 30 at 2:26 PM |
| RSI Alert: CRISPR Therapeutics (CRSP) Now Oversold
www.nasdaq.com - January 23 at 3:58 PM |
| Misplaced Assumptions, Where Investments Go Wrong
seekingalpha.com - January 21 at 8:57 PM |
| 3 Top Biotech Picks for 2020
www.fool.com - January 20 at 1:47 PM |
 | European ruling threatens Broad's CRISPR gene-editing patents
www.bizjournals.com - January 17 at 5:30 PM |
| European ruling threatens Broad's CRISPR gene-editing patents
finance.yahoo.com - January 17 at 5:30 PM |
| SCANS: The FAANG of The Roaring 20s
finance.yahoo.com - January 14 at 9:31 PM |
| Here's Why CRISPR Therapeutics Stock Jumped 113.2% in 2019
www.fool.com - January 9 at 5:52 PM |
| These Top Fund Managers Outperform With Stocks That Many Other Investors Avoid
finance.yahoo.com - January 6 at 4:32 PM |
| CRISPR Therapeutics to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top Conference
finance.yahoo.com - January 6 at 4:32 PM |
| Is Intellia Therapeutics Stock a Buy?
www.fool.com - January 5 at 10:00 AM |
| Better Buy: Crispr Therapeutics vs. Editas
www.fool.com - January 4 at 8:02 AM |
| CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know
finance.yahoo.com - January 3 at 10:01 PM |
| Intellia Therapeutics: A Look Back At 2019 And Forward To 2020
seekingalpha.com - January 2 at 1:21 PM |
| Better Buy: Editas Medicine vs. CRISPR Therapeutics
www.nasdaq.com - December 27 at 12:19 PM |
| This CRISPR Stock Is A 2020 Top Pick — But Will Gene Editing Succeed?
finance.yahoo.com - December 20 at 12:03 PM |
| If You Had Bought CRISPR Therapeutics (NASDAQ:CRSP) Stock Three Years Ago, You Could Pocket A 212% Gain Today
finance.yahoo.com - December 20 at 7:03 AM |
| This Start-up Might Be the Next Gene Editing IPO
www.fool.com - December 19 at 10:55 AM |
| Did Hedge Funds Drop The Ball On CRISPR Therapeutics AG (CRSP) ?
finance.yahoo.com - December 11 at 5:27 PM |
| What the Tech?
finance.yahoo.com - December 11 at 5:27 PM |
| Repare Therapeutics Appoints Steve Forte as CFO and Samarth Kulkarni to Its Board of Directors
finance.yahoo.com - December 3 at 10:35 PM |
